Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Gyroscope Therapeutics $148.0 million Series C equity financing
We advised Gyroscope Therapeutics on its private placement of preferred stock
Nuvei $494 million secondary offering
We advised Nuvei on its secondary offering of subordinate voting shares on a bought deal basis
Macy’s $500 million senior notes offering, tender offer and consent solicitation
We advised the initial purchasers on the high-yield notes offering, concurrent tender offer and related consent solicitation
Owens & Minor $500 million notes offering
We advised the initial purchasers on the high-yield notes offering
Pacific Gas and Electric $2.4 billion first mortgage bonds offering
The high-yield offering included multiple tranches of first mortgage bonds
PetSmart $2.35 billion notes offering
The high-yield offering involved notes due 2028 and 2029
Chesapeake Energy $1 billion notes offering
We advised the initial purchasers on the bond offering for Chesapeake’s emergence from bankruptcy
Hilton $1.5 billion senior notes offering
We advised the initial purchasers on the high-yield notes offering
NYSE secures SEC approval of direct listing rule changes
Davis Polk successfully represented the New York Stock Exchange LLC (“NYSE”) before the Securities and Exchange Commission (the “SEC” or “Commission”) in connection with NYSE’s proposed…